GO
Loading...

Eli Lilly earnings beat

Wednesday, 24 Jul 2013 | 7:20 AM ET

John Lechleiter, chairman, president & CEO, Eli Lilly, says they overcame the loss of patents by growing the sales of other products. The company's focus is beginning to turn to autoimmune diseases.